Engagement design
Build education, activity tracking and accountability around a defined therapeutic pathway.
Pharma & Therapeutic Partners
Explore how measurable exercise engagement and a supported self-management pathway could accompany cardiometabolic therapies, including GLP-1 and lipid-lowering treatments. Potential outcomes require prospective evaluation.
Discuss a partnershipBuild education, activity tracking and accountability around a defined therapeutic pathway.
Define measures and evaluate engagement, feasibility and outcomes without presuming efficacy.
No combination-product, manufacturer-endorsement or drug-subgroup effectiveness claim is implied.